Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | Neuro-oncology Around the World – Global Perspective on Brain Cancer Patient Care

Sunday 04/26/20
02:30 PM - 03:15 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (HeadTalks)
Maciej M. Mrugala, MD, PhD, MPH, FÂé¶¹´«Ã½Ó³»­, Agnieszka Slowik, MD, FÂé¶¹´«Ã½Ó³»­, Alejandro Zavala, MD
General Neurology
No CME available
Patient Care & Procedural Skills
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Event Timeline
02:30 PM - 03:15 PM Speaker Neuro-oncology Around the World – Global Perspective on Brain Cancer Patient Care
Maciej M. Mrugala, MD, PhD, MPH, FÂé¶¹´«Ã½Ó³»­, Agnieszka Slowik, MD, FÂé¶¹´«Ã½Ó³»­, Alejandro Zavala, MD, Riccardo Soffietti, MD
Faculty Disclosures
Maciej M. Mrugala, MD, PhD, MPH, FÂé¶¹´«Ã½Ó³»­ Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Agnieszka Slowik, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer, . Dr. Slowik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Alejandro Zavala, MD Dr. Zavala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Zavala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN.
Riccardo Soffietti, MD Dr. Soffietti has nothing to disclose.